EUR/USD: Better bid as Gilead coronavirus drug offers hope


  • EUR/USD has erased a major portion of losses seen on Thursday.
  • Dollar is being offered on promising signs for coronavirus treatment. 
  • Light data docket leaves the pair at the mercy of the broader market sentiment.

EUR/USD is reversing Thursday's losses as the greenback is on the offer amid risk-on triggered by renewed hopes for coronavirus treatment. 

Euro gains 0.30%

The currency pair is trading at 1.0867 at press time, representing a 0.30% gain on the day, and has recovered nearly 50 percent of the decline from 1.0911 to 1.0817 seen Thursday. 

The safe-haven American dollar is being offered across the board, as the US stock futures and the Asian equities are gaining altitude on optimism generated by the headline from STAT news that Gilead Sciences' experimental drug remdesivir is seeing rapid recoveries in fever and respiratory symptoms associated with the coronavirus. 

Tentative steps to reopen the economy announced by the US President Donald Trump may be adding to bullish pressures around equities. It's worth noting that China reported a bigger-than-expected 6.8% contraction in the gross domestic product for the first quarter during the Asian trading hours. However, Gilead news overshadowed the dismal data and kept risk assets buoyed. 

The market mood is likely to stay pro-risk in Europe. As a result, EUR/USD could continue to gain altitude. On the data front, the Eurozone Consumer Price Index (CPI) is due for release, while the US data calendar is light with just Baker Hughes US Oil Rig Count number expected to hit the wires at 17:00 GMT. 

Technical levels

EUR/USD

Overview
Today last price 1.0867
Today Daily Change 0.0027
Today Daily Change % 0.25
Today daily open 1.084
 
Trends
Daily SMA20 1.0901
Daily SMA50 1.0963
Daily SMA100 1.1032
Daily SMA200 1.1055
 
Levels
Previous Daily High 1.0911
Previous Daily Low 1.0817
Previous Weekly High 1.0952
Previous Weekly Low 1.0768
Previous Monthly High 1.1497
Previous Monthly Low 1.0636
Daily Fibonacci 38.2% 1.0853
Daily Fibonacci 61.8% 1.0875
Daily Pivot Point S1 1.08
Daily Pivot Point S2 1.0761
Daily Pivot Point S3 1.0706
Daily Pivot Point R1 1.0895
Daily Pivot Point R2 1.0951
Daily Pivot Point R3 1.099

 

 

Share: Feed news

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.

Recommended content


Recommended content

Editors’ Picks

EUR/USD clings to daily gains above 1.0650

EUR/USD clings to daily gains above 1.0650

EUR/USD gained traction and turned positive on the day above 1.0650. The improvement seen in risk mood following the earlier flight to safety weighs on the US Dollar ahead of the weekend and helps the pair push higher.

EUR/USD News

GBP/USD recovers toward 1.2450 after UK Retail Sales data

GBP/USD recovers toward 1.2450 after UK Retail Sales data

GBP/USD reversed its direction and advanced to the 1.2450 area after touching a fresh multi-month low below 1.2400 in the Asian session. The positive shift seen in risk mood on easing fears over a deepening Iran-Israel conflict supports the pair.

GBP/USD News

Gold holds steady at around $2,380 following earlier spike

Gold holds steady at around $2,380 following earlier spike

Gold stabilized near $2,380 after spiking above $2,400 with the immediate reaction to reports of Israel striking Iran. Meanwhile, the pullback seen in the US Treasury bond yields helps XAU/USD hold its ground.

Gold News

Bitcoin Weekly Forecast: BTC post-halving rally could be partially priced in Premium

Bitcoin Weekly Forecast: BTC post-halving rally could be partially priced in

Bitcoin price shows no signs of directional bias while it holds above  $60,000. The fourth BTC halving is partially priced in, according to Deutsche Bank’s research. 

Read more

Week ahead – US GDP and BoJ decision on top of next week’s agenda

Week ahead – US GDP and BoJ decision on top of next week’s agenda

US GDP, core PCE and PMIs the next tests for the Dollar. Investors await BoJ for guidance about next rate hike. EU and UK PMIs, as well as Australian CPIs also on tap.

Read more

Forex MAJORS

Cryptocurrencies

Signatures